TY - JOUR
T1 - Evaluation of resting brain conditions measured by two different methods (i.v. And oral administration) with 18F-FDG-PET
AU - Masud, Mehedi
AU - Yamaguchi, Kellehiro
AU - Rikimaru, Hisashi
AU - Tashiro, Manabu
AU - Ozaki, Kaoru
AU - Watanuki, Shoichi
AU - Miyake, Masayasu
AU - Ido, Tatsuo
AU - Itoh, Masatoshi
PY - 2001
Y1 - 2001
N2 - Our aim was to evaluate regional differences between brain activity in two resting control conditions measured by 3D PET after administration of FDG through either the intravenous (i.v.) or the oral route. Ten healthy male volunteers engaged in the study as the i.v. group (mean age, 26 ± 9.3 years, ± S.D.) who received FDG intravenously and another 10 volunteers as the oral group (mean age, 27.9 ± 11.3 years, ± S.D.) who received FDG per os. A set of 3D-PET scans (emission and transmission scans) were performed in both groups. To explore possible functional differences between the brains of the two groups, the SPM-96 software was used for statistical analysis. The results revealed that glucose metabolism was significantly higher in the superior frontal gyrus, superior parietal lobule, lingual gyrus and left cerebellar hemisphere in the i.v. group than in the oral group. Metabolically active areas were found in the superior, middle and inferior temporal gyrus, parahippocampal gyrus, amygdaloid nucleus, pons and cerebellum in the oral group when compared with the i.v. group. These differences were presumably induced by differences between FDG kinetics and/or time-weighted behavioral effects in the two studies. This study suggests the need for extreme caution when selecting a pooled control population for designated activation studies.
AB - Our aim was to evaluate regional differences between brain activity in two resting control conditions measured by 3D PET after administration of FDG through either the intravenous (i.v.) or the oral route. Ten healthy male volunteers engaged in the study as the i.v. group (mean age, 26 ± 9.3 years, ± S.D.) who received FDG intravenously and another 10 volunteers as the oral group (mean age, 27.9 ± 11.3 years, ± S.D.) who received FDG per os. A set of 3D-PET scans (emission and transmission scans) were performed in both groups. To explore possible functional differences between the brains of the two groups, the SPM-96 software was used for statistical analysis. The results revealed that glucose metabolism was significantly higher in the superior frontal gyrus, superior parietal lobule, lingual gyrus and left cerebellar hemisphere in the i.v. group than in the oral group. Metabolically active areas were found in the superior, middle and inferior temporal gyrus, parahippocampal gyrus, amygdaloid nucleus, pons and cerebellum in the oral group when compared with the i.v. group. These differences were presumably induced by differences between FDG kinetics and/or time-weighted behavioral effects in the two studies. This study suggests the need for extreme caution when selecting a pooled control population for designated activation studies.
KW - 3D-PET
KW - FDG
KW - Oral intake
KW - Pooled control
KW - Resting condition
UR - http://www.scopus.com/inward/record.url?scp=0035074111&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035074111&partnerID=8YFLogxK
U2 - 10.1007/BF03012136
DO - 10.1007/BF03012136
M3 - Article
C2 - 11355787
AN - SCOPUS:0035074111
SN - 0914-7187
VL - 15
SP - 69
EP - 73
JO - Annals of Nuclear Medicine
JF - Annals of Nuclear Medicine
IS - 1
ER -